$INKT· News ·

MiNK Therapeutics Cuts Q2 Cash Use 31%

MiNK Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $12.38

+18% in 7d after detection

Post-detection moves

1h
1d
+3.6%
3d
+5.0%
7d
+18%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS